Why Elutia Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket

Gainers

  • Connexa Sports Technologies Inc. CNXA shares rose 73.5% to $0.1313 in pre-market trading after falling 15% on Monday.
  • Elutia Inc. ELUT shares rose 54.8% to $1.92 in pre-market trading after the company announced the sale of its Orthobiologics business unit to Berkeley Biologics LLC.
  • Galera Therapeutics, Inc. GRTX shares rose 21.1% to $0.2309 in pre-market trading. Galera scheduled a Type A meeting with the FDA to discuss next steps for its radiotherapy avasopasem.
  • Senti Biosciences, Inc. SNTI shares gained 20.8% to $0.5860 in pre-market trading after dipping around 17% on Monday.
  • Neptune Wellness Solutions Inc. NEPT rose 17.5% to $5.43 in pre-market trading after falling 18% on Monday. Neptune Wellness announced intention to spinout Sprout Organics pursuant to the Morgan Stanley agreed to transaction.
  • Aclarion, Inc. ACON shares jumped 13.6% to $0.4999 in pre-market trading after falling 12% on Monday.
  • Cybin Inc. CYBN shares surged 12.8% to $0.5190 in pre-market trading. Cybin shares jumped over 39% on Monday after hedge fund owner Steve Cohen invested $19 million in the company.
  • Avinger, Inc. AVGR shares climbed 11.6% to $6.78 in pre-market trading. Avinger shares jumped 47% on Monday amid the company announcing the commercial launch of its Tigereye ST image-guided CTO crossing device.
  • SelectQuote, Inc. SLQT rose 10.6% to $1.25 in pre-market trading. Selectquote COO William Grant, III reported purchase of 150,000 shares at an average price of $1.20 per share in Form 4 filing on Monday.
  • Bit Brother Limited BETS gained 9.7% to $0.68 in pre-market trading.

Losers

  • Digital Transformation Opportunities Corp. DTOC fell 20.8% to $22.97 in pre-market trading after jumping 173% on Monday.
  • Rocket Lab USA, Inc. RKLB shares fell 18.8% to $4.09 in pre-market trading as the company's 41st mission succumbs to technical issues, prompting it to postpone its next mission and revise its third-quarter guidance.
  • Novo Integrated Sciences, Inc. NVOS shares fell 15.7% to $0.2866 in pre-market trading after declining 15% on Monday.
  • 60 Degrees Pharmaceuticals, Inc. SXTP shares fell 15.1% to $0.98 in pre-market trading after the company said it has withdrawn its COVID Phase IIB investigational new drug and announced plans to resubmit pending assessment of ability to meet FDA requirements.
  • Terran Orbital Corporation LLAP fell 14.8% to $1.21 in pre-market trading after the company priced its previously announced public offering of 23.2 million shares and warrants to purchase up to 23.2 million shares at a combined public offering price of $1.40 per share and accompanying warrant.
  • Perspective Therapeutics, Inc. CATX fell 13.8% to $0.2754 in pre-market trading after jumping 56% on Monday.
  • MSP Recovery, Inc. LIFW fell 12.5% to $0.1069 in pre-market trading after dipping 35% on Monday.
  • T2 Biosystems, Inc. TTOO fell 11.1% to $0.4080 in pre-market. T2 Biosystems shares gained over 65% on Monday after the FDA cleared the company's biothreat panel for commercial distribution.
  • SCWorx Corp. WORX fell 10.5% to $0.2337 in pre-market trading after jumping 38% on Monday.
  • FLJ Group Limited FLJ fell 10.1% to $0.2723 in pre-market trading after declining 6% on Monday.

Now Read This: AutoZone, United States Steel And 3 Stocks To Watch Heading Into Tuesday

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!